glp 1 and kidney disease GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog GLP-1 Medications & Their Potential
Description
The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: implications to the animal model of bipolar disorder
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program
Self-injection in the upper arm is difficult
The currently available incretin-based therapies are listed in Table 1 , and their physiologic effects are summarized in Figure 1
